UNP
55
6
NTRS
45
6
SYY
50
-2
URI
70
7
PLD
68
4
BF.B
51
-2
AAPL
56
-3
HAL
39
-9
MCHP
54
4
BBY
51
2
UAL
50
6
AAP
26
2
APD
32
-5
WAT
38
2
LOW
39
-3
UNM
63
2
JPM
66
2
AVY
68
-2
HSIC
40
3
BAC
50
5
UNP
55
6
NTRS
45
6
SYY
50
-2
URI
70
7
PLD
68
4
BF.B
51
-2
AAPL
56
-3
HAL
39
-9
MCHP
54
4
BBY
51
2
UAL
50
6
AAP
26
2
APD
32
-5
WAT
38
2
LOW
39
-3
UNM
63
2
JPM
66
2
AVY
68
-2
HSIC
40
3
BAC
50
5
Financhill
Back

LiqTech International Vs. Keros Therapeutics Industry Stock Comparison

Sell
50

LIQT
LiqTech International

Last Price:
2.25
Seasonality Move:
12.83%
Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
4.22%
Sell
50
LiqTech International (LIQT) is a Sell

Is LiqTech International a Buy, Sell or Hold?

  • The current LiqTech International [LIQT] share price is $2.36. The Score for LIQT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • LIQT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LIQT Stock Price Chart

What is LiqTech International's stock price today?

  • The LiqTech International share price today is $2.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIQT is experiencing slight selling pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

LIQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 46.86 Sell
Chaikin Money Flow: -1546 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.23 - 2.67) Sell
Bollinger Bands (100): (2.49 - 3.15) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

LIQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.23 Buy
20-day SMA: 2.39 Sell
50-day SMA: 2.57 Sell
200-day SMA: 3.21 Sell
8-day EMA: 2.31 Buy
20-day EMA: 2.38 Sell
50-day EMA: 2.56 Sell
200-day EMA: 3.2 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

LiqTech International Earnings Growth & LIQT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.16 per share, a decrease this year of $0.35 per share, and an increase next year of $0.82 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

LiqTech International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):